(For treatment side effects and complications only)
Most hospitals use the Summary Hospital-level Mortality Indicator which reports on mortality at trust level across the NHS in England using a standard and transparent methodology. Specialist trusts are not included in this methodology. However, it is important that we have a clear focus on mortality rates within the hospital and for patients who die elsewhere after receiving treatment from us.
At the Trust we have a comprehensive review programme which includes:
This programme aims to:
We report and review all deaths within 30 days of chemotherapy and radiotherapy treatment. These are divided between radical (potentially curative) and palliative (treatment to relieve or delay the onset of symptoms).
Download our latest reports.
What we are doing to improve:
In accordance with NCEPOD recommendations all deaths within 30 days of treatment are considered at our mortality review meeting. Each consultant also reviews their individual patients. Through this process we aim to continually improve the care and treatment we provide to patients.